Daré Bioscience Prices $6 Million Stock and Warrant Offering

Daré Bioscience has priced a registered direct offering of common stock and warrants, aiming to raise $6.0 million in gross proceeds. A concurrent private placement of Series A and B warrants is also part of the deal. This capital raise is significant for the company's financial operations and future initiatives.